Table 2.
Cox ratio analysis reveals the influence of COVID-19 vaccination on health outcomes and medication usage in the research group with cognitive disorders.
| Not vaccinated | Vaccinated | Adjusted hazard ratio | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | coef | coef lower 95% | coef upper 95% | p value | ||
| 3,543 | 16.86% | 17,470 | 83.14% | −2.99 | −3.12 | −2.86 | p < 0.001 | ||
| Mortality | No | 1,691 | 47.73% | 16,229 | 92.90% | ||||
| Yes | 1852 | 52.27% | 1,241 | 7.10% | |||||
| Positive to COVID-19 | No | 2,471 | 69.74% | 10,978 | 62.84% | −1.1 | −1.25 | −0.96 | p < 0.001 |
| Yes | 1,072 | 30.26% | 6,492 | 37.16% | |||||
| Moved from MCI to dementia | No | 2,846 | 80.33% | 13,441 | 76.94% | 0.17 | 0.04 | 0.3 | p < 0.01 |
| Yes | 697 | 19.67% | 4,029 | 23.06% | |||||
| Purchased antipsychiatry drugs | No | 2,215 | 62.52% | 12,503 | 71.57% | 1.1 | 0.92 | 1.28 | p < 0.001 |
| Yes | 1,328 | 37.48% | 4,967 | 28.43% | |||||
| Prescribed antipsychotics drugs | No | 2,557 | 72.17% | 13,299 | 76.12% | −0.82 | −1.02 | −0.63 | p < 0.001 |
| Yes | 986 | 27.83% | 4,171 | 23.88% | |||||
| Purchased antidepressants | No | 1990 | 56.17% | 7,871 | 45.05% | 0.54 | 0.35 | 0.74 | p < 0.001 |
| Yes | 1,553 | 43.83% | 9,599 | 54.95% | |||||
| Prescribed antidepressants | No | 2,189 | 61.78% | 8,430 | 48.25% | −0.42 | −0.62 | −0.22 | p < 0.001 |
| Yes | 1,354 | 38.22% | 9,040 | 51.75% | |||||
| Depression diagnosis | No | 2,489 | 70.25% | 11,720 | 67.09% | −0.25 | −0.38 | −0.12 | p < 0.001 |
| Yes | 1,054 | 29.75% | 5,750 | 32.91% | |||||
| Home treatments | No | 2,631 | 74.26% | 15,578 | 89.17% | 0.25 | 0.11 | 0.39 | p < 0.001 |
| Yes | 912 | 25.74% | 1892 | 10.83% | |||||
| Bone fractures | No | 3,286 | 92.75% | 15,456 | 88.47% | −0.14 | −3.22 | 2.94 | 0.46 |
| Yes | 257 | 7.25% | 2014 | 11.53% | |||||
| Hip fracture | No | 3,286 | 92.75% | 15,456 | 88.47% | −0.14 | −3.22 | 2.94 | 0.46 |
| Yes | 257 | 7.25% | 2014 | 11.53% | |||||
| Registered blood pressure | No | 607 | 17.13% | 3,727 | 21.33% | 0.07 | −0.07 | 0.22 | 0.17 |
| Yes | 2,936 | 82.87% | 13,743 | 78.67% | |||||
| Registered COPD | No | 3,214 | 90.71% | 15,684 | 89.78% | 0.19 | 0.01 | 0.37 | p < 0.05 |
| Yes | 329 | 9.29% | 1786 | 10.22% | |||||
| Registered diabetes | No | 2071 | 58.45% | 10,722 | 61.37% | 0.36 | 0.24 | 0.48 | p < 0.001 |
| Yes | 1,472 | 41.55% | 6,748 | 38.63% | |||||
| Registered immunosuppression | No | 2,650 | 74.80% | 13,844 | 79.24% | 0.52 | 0.4 | 0.64 | p < 0.001 |
| Yes | 893 | 25.20% | 3,626 | 20.76% | |||||
| Registered obesity | No | 2,994 | 84.50% | 12,853 | 73.57% | −5.14 | −6.41 | −3.87 | p < 0.001 |
| Yes | 549 | 15.50% | 4,617 | 26.43% | |||||
The Cox proportional hazard model was constructed for the outcome events of the two study groups considering a previous history of outcome events, having tested positive to COVID-19, using antipsychotics drugs, using antidepressants, having depression diagnosis, bone fractures, and different registered medical conditions as covariates, weighted by the inverse probability of full vaccination.